Form 4: Equillium COO Sells Shares Via Pre-Planned Trading Plan
Insider Transaction Report
Equillium's Senior Vice President and COO, Christine Zedelmayer, sold 8,098 shares of common stock through a pre-arranged Rule 10b5-1 trading plan.
Summary
- Christine Zedelmayer, Senior Vice President and Chief Operating Officer of Equillium, Inc., reported sales of common stock.
- On November 25, 2025, Zedelmayer sold 100 shares of common stock at a price of $0.98 per share.
- On the same date, an additional 7,998 shares of common stock were sold at a price of $0.95 per share.
- These transactions were executed pursuant to a Rule 10b5-1 trading plan, which was adopted by the reporting person on August 27, 2025.
- Following these sales, Christine Zedelmayer directly beneficially owns 127,148 shares of Equillium common stock.
Sentiment
Score: 5
Explanation: Neutral. While an insider sale, it was conducted under a pre-arranged 10b5-1 plan, which mitigates concerns about opportunistic selling. The amount sold is also relatively small compared to total holdings.
Negatives
- Insider selling, even when pre-planned, can sometimes be interpreted negatively by some investors, potentially suggesting a lack of confidence, although this is often not the case with Rule 10b5-1 plans.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Insider Trading Plan | Christine Zedelmayer's sales were executed under a Rule 10b5-1 trading plan, adopted on August 27, 2025. This is a standard corporate governance practice that allows insiders to sell shares without concerns of trading on material non-public information, as the plan is established in advance. | 08/27/2025 | Enhances transparency and reduces potential for insider trading allegations by demonstrating pre-planned, non-discretionary sales. |
Stakeholder Impact
- Shareholders may note the reduction in direct ownership by a key executive, though the pre-planned nature of the sale under Rule 10b5-1 typically lessens negative interpretations regarding management's confidence in the company's future.
Key Dates
| Date | Description |
|---|---|
| 08/27/2025 | Date Rule 10b5-1 trading plan was adopted by Christine Zedelmayer. |
| 11/25/2025 | Date of common stock sales by Christine Zedelmayer. |
Recommendation
holdThe filing reports a routine insider stock sale executed under a pre-arranged Rule 10b5-1 plan. This type of transaction is generally not indicative of a change in company fundamentals or management's long-term outlook. Therefore, it does not provide sufficient new information to warrant a change from a 'hold' recommendation based solely on this filing.
Keywords
Equillium, EQ, Christine Zedelmayer, Insider Trading, Form 4, Stock Sale, 10b5-1 Plan, Corporate Officer, COO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.